TELA Bio, Inc.
Cash Flow Statement
| Line Item | FY2017 |
|---|---|
| Operating Activities | |
| Net Income | $-21.3M |
| Depreciation & Amortization | — |
| Depreciation | $761.0K |
| Amortization | — |
| Stock-Based Compensation | $197.0K |
| Net Cash from Operating Activities | $-16.4M |
| Investing Activities | |
| Capital Expenditures | $114.0K |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $-101.0K |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $26.3M |
| Net Change in Cash | $9.9M |
| Free Cash Flow | $-16.5M |